Record Adjusted EBITDA
Achieved a record $23 million in adjusted EBITDA, marking the fifth consecutive quarter of positive adjusted EBITDA and a 4x improvement over the same quarter last year.
Significant Revenue Growth
Total revenue reached $186 million, a 27% increase year-over-year, with surgical revenue growing by 29%.
Strong Cash Position
Ended the quarter with $217 million in cash and available cash, demonstrating strong cash management and financial stability.
Market Share Achievement
Achieved the position of third in market share in the U.S. spine market, indicating strong competitive positioning.
Surgeon User Growth
Surgeon user growth reached 21%, reflecting strong adoption and demand for ATEC's products.
Positive Free Cash Flow
Generated $5 million in free cash flow, reinforcing the company's profitability and cash generation capabilities.
Increased Full-Year Guidance
Raised full-year revenue guidance by $8 million to $742 million, reflecting confidence in continued strong performance.